The urinary concentration of sialic acid is increased in non-insulin-dependent diabetic patients with microangiopathy: A possible useful marker for diabetic microangiopathy

被引:6
作者
Suzuki, K
Ishida, H
Sugimoto, C
Taguchi, Y
Matsuda, H
Nosaka, K
Someya, Y
Kadowaki, S
Seino, Y
机构
[1] Department of Metabolism and Clinical Nutrition, Kyoto University School of Medicine, Kyoto
[2] Departments of Clinical Laboratory Medicine, Shimada Municipal Hospital, Shizuoka
[3] Departments of Internal Medicine, Shimada Municipal Hospital, Shizuoka
[4] Shimada Municipal Hospital, Shizuoka
[5] Division of Clinical Nutrition and Metabolism, Faculty of Health Science, Suzuka University of Medical Science and Technology, Mie
关键词
sialic acid; diabetic microangiopathy; glomerular basement membrane; retinopathy; nephropathy;
D O I
10.1111/j.1464-5491.1995.tb00426.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In order to investigate the relationship between urinary excretion of sialic acid and the severity of diabetic microangiopathy, urinary levels of sialic acid were determined in patients with non-insulin-dependent diabetes mellitus. The urinary molar ratio of sialic acid to creatinine in the diabetic patients was significantly higher than in the healthy controls (p < 0.01). Moreover, the urinary ratio was found to be gradually increased with the degree of diabetic microangiopathy. Urine molar ratio of sialic acid to creatinine in patients with proliferative diabetic retinopathy was significantly higher than in patients without retinopathy (p < 0.01). Urinary excretion in patients with macroproteinuria was also significantly higher than in patients without nephropathy (p < 0.01). Since urinary levels of sialic acid are proportionally increased with the severity of diabetic microangiopathy, the measurement of urinary sialic acid could become a useful biochemical means to monitor the degree of diabetic microangiopathy.
引用
收藏
页码:1092 / 1096
页数:5
相关论文
共 11 条
[1]  
Ujjaini K., James K., Barton G., Serum sialic acid is a biologenic marker for malignant disease, J Surg Oncol, 23, pp. 163-166, (1983)
[2]  
Blau EB, Haas JE, Glomelular sialic acid and proteinuria in human renal disease, Lab Invest, 28, pp. 477-481, (1973)
[3]  
Spiro RG, Investigation into the biochemical basis of diabetic glomerular basement alterations, Diabetes, 25, (1976)
[4]  
Ajello LM, Cavallerano JD, Ocular complications of diabetes mellitus, Joslin's Diabetes Mellitus, pp. 771-793, (1994)
[5]  
Araki H., Yamada M., Sialic acid, Method of Enzymatic Analysis, 4, pp. 80-90, (1984)
[6]  
Senju O., Takagi Y., Uzawa R., Iwasaki Y., Suzuki T., Gomi K., Et al., A new immuno quantitative method by latex agglutination, J Clin Lab Immunol, 19, pp. 99-103, (1986)
[7]  
Flore M., Mitchell J., Doan T., Nelson R., Winter G., Grandone C., The Abbott IMX automated benchtop immunochemistry analyzer system, Clin Chem, 34, pp. 1726-1732, (1988)
[8]  
Tanssky HH, A microcolorimetric determination of creatinine in urine by the Jaffe reaction, J Biol Chem, 208, pp. 853-861, (1954)
[9]  
Schvartz LS, Paukman LI, Diabetic angiopathies and mucopolysaccharide Metabolism, Probl Endocrinol, 17, pp. 37-41, (1971)
[10]  
Crook MA, cp JY, cp KE, Viberti GV, Morocutti A., Pickup JC, Serum sialic acid, a risk factor for cardiovascular disease, is increased in IDDM patients with microalbuminuria and clinical proteinuria, Diabetes Care, 17, pp. 305-309, (1994)